MHRA pauses PATHWAYS clinical trial after raising new safety concerns for children and young people in the United Kingdom

[»] Jump to Summary... Plans for the PATHWAYS clinical trial, which aims to study the prescription of puberty blockers for children and young people experiencing gender incongruence, have been put on hold. The pause comes after the Medicines and Healthcare products Regulatory Agency (MHRA) flagged new concerns about the study’s safety and methodology. What the

Read More